ZIM
IMGN

Zacks Investment Management’s Immunogen Inc IMGN Stock Holding History

Zacks Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,735
Closed -$259K – 730
2023
Q4 		$259K Sell
8,735
-45,289
-84% -$902K ﹤0.01% 550
2023
Q3 		$857K Buy
54,024
+5,806
+12% +$96.6K 0.01% 392
2023
Q2 		$910K Buy
+48,218
New +$569K 0.01% 387
2019
Q4 		– Sell
-10,259
Closed -$25K – 611
2019
Q3 		$25K Sell
10,259
-33,365
-76% -$88.6K ﹤0.01% 513
2019
Q2 		$95K Buy
43,624
+33,476
+330% +$79.2K ﹤0.01% 515
2019
Q1 		$28K Sell
10,148
-1,180
-10% -$5.11K ﹤0.01% 529
2018
Q4 		$54K Sell
11,328
-2,486
-18% -$15.1K ﹤0.01% 491
2018
Q3 		$131K Buy
+13,814
New +$133K ﹤0.01% 497
2018
Q1 		– Sell
-19,594
Closed -$126K – 641
2017
Q4 		$126K Sell
19,594
-2,180
-10% -$13.4K ﹤0.01% 550
2017
Q3 		$167K Buy
+21,774
New +$145K ﹤0.01% 545
2016
Q4 		– Sell
-12,130
Closed -$33K – 760
2016
Q3 		$33K Hold
12,130
– – ﹤0.01% 641
2016
Q2 		$37K Sell
12,130
-125
-1% -$784 ﹤0.01% 614
2016
Q1 		$104K Buy
+12,255
New +$104K ﹤0.01% 590

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zacks Investment Management's IMGN Position: Q1 2024 in Review

Zacks Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 8,735 shares — an estimated $259K sold.

Zacks Investment Management first reported a position in IMGN in Q1 2016 and held it in 13 quarters. The position peaked at $910K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Zacks Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Zacks Investment Management sold 8,735 Immunogen Inc shares in Q1 2024, an estimated $259K.
  • Zacks Investment Management first reported a position in Immunogen Inc in Q1 2016 and held it in 13 quarters.
  • Zacks Investment Management's Immunogen Inc position peaked at $910K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Zacks Investment Management's 13F filing for Q1 2024, filed 15 May 2024.